Zivo Bioscience Capital Expenditures (CapEx) Growth & History (ZIVO)

Zivo Bioscience's capital expenditures (capex) was $0 for fiscal 2014.

View full Zivo Bioscience company overview

Zivo Bioscience annual capital expenditures (capex) history

Zivo Bioscience annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20142014-12-31$0$0
20132013-12-31$0−$3,500
20122012-12-31$3,500−$1,220−25.85%
20112011-12-31$4,720−$24,909−84.07%
20102010-12-31$29,629

Zivo Bioscience capital expenditures (capex) trends

Between the periods ended 2010-12-31 and 2014-12-31, Zivo Bioscience's capital expenditures (capex) decreased from $29,629 to $0, a change of −$29,629. The latest reported quarter, Q3 2013, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Zivo Bioscience source filings ↗

Community posts

It’s quiet here.

No posts about ZIVO yet. Start the conversation.

Write the first post